Gene · 9407
Papers3,095
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,095
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart. | J Precis Med (Amst) | 2026 | 42644057 | PubTator, text mining | PubMed |
| HAT regimen attenuates NF-κb-driven megakaryocyte apoptosis and neuronal cell death in sepsis: convergent mechanisms protecting thrombocytopenia and cognitive function. | Front Cell Dev Biol | 2026 | 42548835 | PubTator, text mining | PubMed |
| Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications. | Pharmacol Res | 2026 | 42468581 | PubTator, text mining | PubMed |
| Acetylation as a dynamic regulatory interface between plant stress memory, cross-tolerance, and crop resilience design. | Front Plant Sci | 2026 | 42389139 | PubTator, text mining | PubMed |
| Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches. | Cancer Immunol Immunother | 2026 | 42215810 | PubTator, text mining | PubMed |
| αKG-mediated carnitine synthesis drives DNA repair via histone acetylation. | Nature | 2026 | 42203879 | PubTator, text mining | PubMed |
| Unraveling the layers of epigenetic control in respiratory antiviral defense. | J Virol | 2026 | 42159289 | PubTator, text mining | PubMed |
Promising Synthetic Antioxidants of Dimethyltin(IV) Formulations Derived From 4-Acylated Edaravone: Design, DFT Assisted Optimized Molecular Structure and Mechanistic Insights into SET Versus HAT Pathways for Antioxidant Activity. | J Biochem Mol Toxicol | 2026 | 42101074 | PubTator, text mining | PubMed |
| Radical Quenching and LOX Inhibiting Properties of Indole Derivatives: A Plausible Mechanism of Action Through HAT, SET-PT and SPLET Pathway. | J Fluoresc | 2026 | 42090043 | PubTator, text mining | PubMed |
| Genetic mutations and inhibitors of p300 and CBP. | Biochim Biophys Acta Rev Cancer | 2026 | 42061730 | PubTator, text mining | PubMed |
| Emerging Insights into Hereditary Alpha-Tryptasemia in the Context of Mast Cell Disorders: A Greek Case Series. | J Pers Med | 2026 | 42042563 | PubTator, text mining | PubMed |
| Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy. | Ann Med | 2026 | 41918250 | PubTator, text mining | PubMed |
| How to Employ Trained Immunity and Trained Immunity-Based Vaccines to Inhibit Allergic Inflammation. | Vaccines (Basel) | 2026 | 41893804 | PubTator, text mining | PubMed |
| Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay. | Epigenomes | 2026 | 41892363 | PubTator, text mining | PubMed |
| Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women. | Cells | 2026 | 41892319 | PubTator, text mining | PubMed |
| The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma. | Cell Oncol (Dordr) | 2026 | 41874858 | PubTator, text mining | PubMed |
| Epigenetic regulation in a high-sugar environment (Review). | Int J Mol Med | 2026 | 41860052 | PubTator, text mining | PubMed |
| Towards broad-spectrum antiviral drugs: inhibition of transmembrane serine proteases. | Biochem J | 2026 | 41847980 | PubTator, text mining | PubMed |
| Synthesis of Isochromans From Anacardic Acids Obtained From Cashew Nutshell Liquid (CNSL) and Their Antimicrobial Activity. | Chem Biodivers | 2026 | 41838549 | PubTator, text mining | PubMed |
| Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell-Based Therapies. | FASEB J | 2026 | 41837732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9407/papers